New Lyme Disease Vaccine Shows Promise in Phase 3 Trial

新型萊姆病疫苗在第三期臨床試驗中展現成效

A significant breakthrough in medical research occurred in March 2026, as Pfizer and Valneva announced the Phase 3 results for their Lyme disease vaccine candidate, VLA15.

2026年3月，醫療研究取得重大突破，輝瑞與Valneva宣布了其萊姆病疫苗候選者VLA15的第3期試驗結果。

orgPfizer

orgValneva

conceptLyme disease

techVLA15

Lyme disease is the most common vector-borne illness in the Northern Hemisphere, yet there is currently no approved vaccine available for human use.

萊姆病是北半球最常見的病媒傳染病，但目前尚無核准供人類使用的疫苗。

conceptLyme disease

locationNorthern Hemisphere

The VALOR clinical trial tested the vaccine's efficacy in nearly 9,500 participants across North America and Europe.

VALOR臨床試驗在北美與歐洲招募了近9500名參與者，以測試該疫苗的效力。

eventVALOR

locationNorth America

locationEurope

🎉

文章閱讀結束

你閱讀了 3 句重點內容。

挑戰模式

閱讀理解

What is the primary way VLA15 protects humans from Lyme disease?

It creates a permanent skin barrier against tick bites.

It destroys the tick's salivary glands instantly.

It produces antibodies that neutralize bacteria inside the tick's gut.

查看答案

✓

正確答案

It produces antibodies that neutralize bacteria inside the tick's gut.

Why did the trial narrowly miss its primary statistical endpoint?

The vaccine was found to be ineffective in children.

There were fewer Lyme disease cases than researchers anticipated.

Too many participants dropped out due to side effects.

查看答案

✓

正確答案

There were fewer Lyme disease cases than researchers anticipated.

What happened to the previous Lyme disease vaccine, LYMERix?

It was banned by the FDA due to severe safety risks.

It was discontinued in 2002 due to low public demand and concerns.

It was never approved for public use by authorities.

查看答案

✓

正確答案

It was discontinued in 2002 due to low public demand and concerns.

Which of these statements about the VLA15 trial is true?

The trial failed to reach a secondary analysis threshold.

The trial involved participants from North America and Europe.

The trial was completed in under six months.

查看答案

✓

正確答案

The trial involved participants from North America and Europe.

How many doses were required in the VALOR trial schedule?

Four doses.

Six doses.

Two doses.

查看答案

✓

正確答案

Four doses.

使用 Ringoo App 學習更快速

追蹤你的學習進度，並透過互動式練習獲得即時回饋。

App Store Google Play